iBiopsy®: Median Technologies Continues Its Strong Positioning in Early-Stage Diagnosis with a New iBiopsy® Clinical Development Plan on Lung Cancer Screening (LCS)

SOPHIA ANTIPOLIS, France–(BUSINESS WIRE)—- $ALMDT #IA–iBiopsy®: Median Technologies continues its strong positioning in early-stage diagnosis

---